Fangda Group Northeast Pharmaceutical overcomes production challenges to achieve full capacity, with the output of key products increasing nearly 15% year-on-year to secure a strong start.

(Source: Shenyang Daily)

Transferred from: Shenyang Daily

The production front line is the main battlefield for supply assurance and a core area for enterprises to sprint for quarterly “opening red.” In the first quarter, Liaoning Fangda Group Northeast Pharmaceutical operated all its plants at full capacity, with core product output steadily increasing. In the first two months of this year, the output of key products grew nearly 15% year-on-year, with core varieties such as Vitamin C and Piracetam successfully passing audits from multiple international clients, gaining recognition in the international market for production strength and product quality.

Plant 204, as the core production base for L-Carnitine and its series of products, faced strong demand for all series of products during the holiday period. It optimized production scheduling, refined process connections, and simultaneously promoted the production of multiple products, ultimately achieving a historic high in the storage output of L-Carnitine and its series in February. Other production plants also made concerted efforts, with production lines for key raw materials such as Berberine Hydrochloride and Phosphomycin operating at full capacity. The small-volume formulation production line relied on intelligent equipment to achieve fully automated operations for bottle washing, filling, and boxing, significantly improving production efficiency.

The hard-core supply from the production end relies on efficient collaboration and close coordination across all links of the industrial chain. Northeast Pharmaceutical has always strictly adhered to the bottom line of drug quality while simultaneously digging deep into cost reduction and efficiency improvement potential, achieving quality control and cost management. The raw material inspection center’s R&D team closely collaborated with the sales department to accurately meet customer needs, successfully completing the sampling and verification of inspection methods specified by clients, laying a solid foundation for deepening cooperation and expanding orders. The formulation inspection center’s chemical testing line supply assurance team has completed nearly 1,300 batches of drug inspections from the beginning of the year to March 24, achieving 100% qualified quality for outgoing products and reinforcing the quality defense line throughout the process. The procurement and supply assurance center closely followed production demands, conducted in-depth market research with suppliers, precisely grasped raw material price trends, and achieved cost reduction and efficiency improvement through deepening strategic cooperation. At the same time, it dynamically monitored the entire cycle of procurement, production, and transportation of key materials, building a more resilient supply chain system to ensure stable production operations.

Shenyang Daily, Shenyang News All-Media Reporter Huang Chao

Massive information, precise interpretation, all in the Sina Finance APP